3D Bioprinting Market Size to Reach USD 3,244.17 Million in 2028 | Industry Trend – High Investments by Pharmaceutical and Biotechnology Companies in Stem Cell Research

According to Emergen Research, the global 3D bioprinting market size was USD 773.92 million in 2020 and is expected to reach USD 3,244.17 million in 2028 and register a revenue CAGR of 20.7% during the forecast period, 2021-2028.

Emergen Research has published its latest report titled “3D Bioprinting Market, By Material Type (Hydrogels, Living Cells, Extracellular Matrices, Others), By Technology (Laser-based, Inkjet-based, Syringe-based, Magnetic Levitation, Others), By Application (Clinical Applications, Research Applications), and By Region Forecast to 2028”

According to Emergen Research, the global 3D bioprinting market size was USD 773.92 million in 2020 and is expected to reach USD 3,244.17 million in 2028 and register a revenue CAGR of 20.7% during the forecast period, 2021-2028.

Market Dynamics:

Revenue growth of the global 3D bioprinting market is primarily attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing public and private investments in medical research, emergence of next-generation 3D bioprinting techniques such as computer-assisted design (CAD), robotic bioprinting, and tissue formation modelling, and rapid adoption of advanced 3D bioprinters and biomaterials for pharmaceutical and biotechnological applications.

3D bioprinting utilizes three-dimensional printing techniques to combine cells and biomaterials to fabricate biomedical parts that mimic the natural characteristics of the specific tissue and organs. Key applications of 3D bioprinting include drug research & development and reconstruction of damaged tissue, joints, or ligaments. Hence, increasing applications of 3D bioprinting in pharmacology (personalized medicine, additive pill manufacturing) and cosmetology (cell therapy, skin substitutes, wound-healing treatments), rising prevalence of different types of cancer, growing investments in stem cell research, and increasing adoption of regenerative medicine are some of the other key factors expected to drive the global 3D bioprinting market revenue growth.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/133

Amid the coronavirus pandemic and shortage of COVID-19 test kits and equipment, several healthcare companies have developed 3D bioprinters and related software that can be used in the large-scale manufacture of these equipment. For instance, leading American 3D printing company, Stratasys, manufactured face shields using its advanced 3D bioprinters, and distributed up to 100,000 face shields in the U.S. in March 2020.

COVID-19 Impact Analysis:

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Living Cells Segment Accounted for Largest Revenue Share in 2020:

The living cells segment dominated other material type segments in terms of largest revenue share in the global market in 2020. Increasing research & development activities in the field of regenerative medicine, rise in public and private investments in stem cell research, and rapid adoption of next-generation 3D bioprinting technologies are primary factors driving revenue growth of this segment.

Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/133

Clinical Applications Segment to Account for Fastest Revenue CAGR:

The clinical applications segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Rising prevalence of various chronic and acute diseases, increasing need for cost-effective medicine, and increasing clinical applications of 3D bioprinting such as drug development and tissue and organ regeneration are among the major factors driving this segment’s revenue growth.

North America Accounted for Largest Revenue Share in 2020:

Among the regional markets, the North America 3D bioprinting market accounted for the largest revenue share in the global market in 2020. Key factors contributing to revenue growth of the North America market are rapid adoption of advanced 3D bioprinting techniques, rising focus on development of regenerative medicine, increasing applications of 3D bioprinting in cosmetology, and presence of state-of-the-art healthcare infrastructure and leading market players in the region, including Nano3D Biosciences, Inc., Allevi Inc., and Organovo Holdings, Inc.

Major Companies in the Global 3D Bioprinting Market Include:

  • Digilab, Inc.
  • Organovo Holdings, Inc.
  • Allevi Inc.
  • CELLINK
  • Cyfuse Biomedical K.K.
  • EnvisionTEC GmbH
  • Aspect Biosystems Ltd.
  • Poietis
  • TeVido BioDevices
  • Nano3D Biosciences, Inc.
  • ROKIT Healthcare
  • REGENHU
  • GeSiM GmbH
  • Advanced Solutions Life Sciences
  • Regenovo Biotechnology Co., Ltd.

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/3d-bioprinting-market

For the purpose of this report, Emergen Research has segmented the global 3D bioprinting market based on material type, technology, application, and region:

Material Type Outlook (Revenue, USD Million; 2018–2028)

  • Hydrogels
  • Extracellular Matrices
  • Living Cells
  • Others

Technology Outlook (Revenue, USD Million; 2018–2028)

  • Inkjet-based
  • Laser-based
  • Syringe-based
  • Magnetic Levitation
  • Others

Application Outlook (Revenue, USD Million; 2018–2028)

  • Clinical Applications
  • Blood Vessels
  • Skin
  • Research Applications
  • Regenerative Medicine
  • 3D Cell Culture
  • Drug Development

Region Outlook (Revenue, USD Million; 2018–2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of Middle East & Africa

Explore our reports from Healthcare Catogory:

Increasing advancements in sequencing techniques, benefits of Sanger’s sequencing, and rising investments to accelerate R&D activities in genomics research are key factors expected to drive sanger sequencing services market revenue growth over the forecast period.

Advancements in genomic research, rapid adoption of cutting-edge technologies, and increasing awareness about whole exome sequencing technology are key factors expected to drive whole exome sequencing (WES) market revenue growth over the forecast period.

The global health data archiving market size was USD 3.21 Billion in 2020 and is expected to reach USD 9.28 Billion in 2028 and register a CAGR of 14.1%. Healthcare data archiving industry report classifies global market by share, trend, growth and on the basis of type, storage system, deployment, architecture, end-use, and region.

The global naval Intelligence, Surveillance, Reconnaissance market size was USD 13.17 Billion in 2020 and is expected to reach USD 16.24 Billion in 2028 registering a CAGR of 2.6%. Naval ISR industry report classifies global market by share, trend, growth and on the basis of vessel type, application, and region.

The global emerging memory technologies market size reached USD 4.17 Billion in 2020 and is expected to reach USD 34.66 Billion in 2028 registering a CAGR of 30.7%. Emerging memory technologies industry report classifies global market by share, trend, growth and on the basis of technology, application, and region.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-3d-bioprinting-market